articles
- Carnosic acid attenuates cartilage degeneration through induction of heme oxygenase-1 in human articular chondrocytes. 830:1-8. 2018
- The dark side of emotion: The addiction perspective. 753:73-87. 2015
- The triple reuptake inhibitor dov 216,303 induces long-lasting enhancement of brain reward activity as measured by intracranial self-stimulation in rats. 693:51-56. 2012
- Both gaba(b) receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats. 655:52-58. 2011
- In vitro pharmacological selectivity profile of oseltamivir prodrug (tamiflu (r)) and active metabolite. 628:6-10. 2010
- Kr-003048, a potent, orally active inhibitor of p38 mitogen-activated protein kinase. 632:93-102. 2010
- Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice. 649:210-217. 2010
- Loganin improves learning and memory impairments induced by scopolamine in mice. 619:44-49. 2009
- Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist. 590:423-429. 2008
- Differential modulation of inflammatory pain by a selective estrogen receptor beta agonist. 592:158-159. 2008
- Time-dependent involvement of cAMP and cGMP in consolidation of object memory: Studies using selective phosphodiesterase type 2, 4 and 5 inhibitors. 558:107-112. 2007
- Activators of potassium m currents have anticonvulsant actions in two rat models of encephalitis. 555:23-29. 2007
- Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors. 557:44-48. 2007
- 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. 487:125-132. 2004
- Cannabinoid receptor antagonist reduces heroin self-administration only in dependent rats. 501:235-237. 2004
- Ethanol-induced increases in neuroactive steroids in the rat brain and plasma are absent in adrenalectomized and gonadectomized rats. 484:241-247. 2004
- No evidence for G-protein-coupled epsilon receptor in the brain of triple opioid receptor knockout mouse. 492:131-136. 2004
- Reinforcing effect of pseudoephedrine isomers and the mechanism of action. 493:117-125. 2004
- Agonist properties of putative small-molecule somatostatin sst(2) receptor-selective antagonists. 465:211-218. 2003
- Systemic galnon, a low-molecular weight galanin receptor agonist, reduces heat hyperalgesia in rats with nerve injury. 482:133-137. 2003
- Pharmacological characterisation of the goldfish somatostatin sst(5) receptor. 436:173-186. 2002
- Lack of reward and locomotor stimulation induced by heroin in mu-opioid receptor-deficient mice. 446:103-109. 2002
- Lack of evidence for cross-competition between vasoactive intestinal peptide and somatostatin at their respective receptors. 426:165-173. 2001
- Effect of nociceptin/orphanin FQ on the rewarding properties of morphine. 404:153-159. 2000
- Neurobiological mechanisms by which nicotine mediates different types of anxiety. 393:231-236. 2000
- The galanin receptor antagonist m40 blocks the central cardiovascular actions of the galanin n-terminal fragment (1-15). 399:197-203. 2000
- beta-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cells. 402:R1-R3. 2000
- Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat. 375:115-120. 1999
- A heroin-, but not a cocaine-expecting, self-administration state preferentially alters endogenous brain peptides. 365:175-182. 1999
- Antagonism of heroin and morphine self-administration in rats by the morphine-6 beta-glucuronide antagonist 3-o-methylnaltrexone. 383:115-119. 1999
- Chronic ethanol enhances muscarinic receptor-mediated activator protein-1 (ap-1) DNA binding in cerebellar granule cells. 383:203-208. 1999
- Gamma-hydroxybutyrate inhibits excitatory postsynaptic potentials in rat hippocampal slices. 380:109-116. 1999
- Region specific expression of nmda receptor nr1 subunit mrna in hypothalamus and pons following chronic morphine treatment. 365:47-54. 1999
- I-125 Tyr(3) octreotide labels human somatostatin sst(2) and sst(5) receptors. 348:311-320. 1998
- Genomic cloning and species-specific properties of the recombinant canine beta(3)-adrenoceptor. 363:217-227. 1998
- Dextromethorphan reduces intravenous cocaine self-administration in the rat. 321:279-283. 1997
- Intravenous self-administration of heroin, cocaine, and the combination in balb/c mice. 326:119-125. 1997
- Opposite effects of stress on dopamine release in the limbic system of drug-naive and chronically amphetamine-treated rats. 337:219-222. 1997
- The anxiolytic-like effects of the neurosteroid allopregnanolone: Interactions with gaba(a) receptors. 325:1-7. 1997
- A non peptidic corticotropin releasing factor receptor antagonist attenuates fever and exhibits anxiolytic-like activity. 309:195-200. 1996
- Adenosine a(2a) receptors modulate the binding characteristics of dopamine d-2 receptors in stably cotransfected fibroblast cells. 316:325-331. 1996
- Dopamine partial receptor agonists reduce ethanol intake in the rat. 296:233-238. 1996
- Fragments of galanin message-associated peptide (GMAP) modulate the spinal flexor reflex in rat. 318:301-306. 1996
- Inhibition of dynorphin-converting enzymes prolongs the antinociceptive effect of intrathecally administered dynorphin in the mouse formalin test. 314:61-67. 1996
- N-methyl-d-aspartate-induced enhancement of activator protein-1 DNA binding activity is blocked by ethanol in cerebellar granule cells. 309:307-310. 1996
- Gaba(a) receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. 283:151-159. 1995
- Peptoid cck receptor antagonists: Pharmacological evaluation of ccka, cckb and mixed ccka/b receptor antagonists. 286:185-191. 1995
- The dopamine-receptor agonist 7-oh-dpat modulates the acquisition and expression of morphine-induced place preference. 274:47-55. 1995
- Antagonistic regulation of alpha(2)-adrenoceptors by neuropeptide-y receptor subtypes in the nucleus-tractus-solitarii. 271:201-212. 1994
- Biological activities of two endogenously occurring N-terminally extended forms of galanin in the rat spinal cord. 259:151-156. 1994
- Characterization of galanin and 5-ht1a receptor coupling to adenylyl-cyclase in discrete regions of the rat-brain. 269:209-217. 1994
- Differential dopaminergic regulation of the neurotensin striatonigral and striatopallidal pathways in the rat. 262:1-10. 1994
- Evidence for an antagonistic angiotensin-ii alpha(2)-adrenoceptor interaction in the nucleus-tractus-solitarii. 262:271-282. 1994
- Galanin message-associated polypeptide (GMAP) does not affect insulin secretion from isolated islets. 259:79-82. 1994
- Intracisternally injected galanin-(1-15) modulates the cardiovascular-responses of galanin-(1-29) and the 5-ht1a receptor agonist 8-oh-dpat. 257:257-265. 1994
- Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. 253:45-51. 1994
- Influence of Ca2+ channel agonists and antagonists on the post-rest staircase. 237:83-92. 1993
- Blockade of galanin-induced inhibition of insulin secretion from isolated mouse islets by the non-methionine containing antagonist M35. 232:35-39. 1993
- The c-terminal neurotensin-(8-13) fragment potently modulates rat neostriatal dopamine-d(2) receptors. 234:125-128. 1993
- Evidence for specific n-terminal galanin fragment binding-sites in the rat-brain. 224:203-205. 1992
- In vitro study of a novel atypical beta-adrenoceptor agonist, SM-11044. 216:207-215. 1992
- The novel high-affinity antagonist, galantide, blocks the galanin-mediated inhibition of glucose-induced insulin secretion. 210:183-188. 1992
- Centrally coinjected galanin and a 5-ht1a agonist act synergistically to produce vasodepressor responses in the rat. 204:87-95. 1991
- Galanin-induced inhibition of insulin secretion from rat islets: effects of rat and pig galanin and galanin fragments and analogues. 203:111-114. 1991
- Inhibition of prolactin secretion by endothelin-3 is pertussis toxin-sensitive. 198:223-225. 1991
- The N-terminal 1-16, but not C-terminal 17-29, galanin fragment affects the flexor reflex in rats. 182:137-141. 1990
- Two pharmacological classes of quisqualate-induced electrical responses in rat retinal ganglion cells in vitro. 174:9-22. 1989
- Pharmacologic profile of lipoxin-a5 and lipoxin-b5 - new biologically-active eicosanoids. 163:55-60. 1989
- Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (gaba), dynorphin-a and substance-p. 147:411-420. 1988
- Galanin inhibits the muscarinic stimulation of phosphoinositide turnover in rat ventral hippocampus. 148:479-480. 1988
- Altered binding-properties of beta-adrenergic receptors and lack of coupling to adenylate-cyclase in p815 mastocytoma-cells. 108:133-141. 1985
- In vitro and in vivo inhibition of [3H]imipramine binding by cadmium. 90:289-292. 1983
- Adrenal steroid-induced changes in beta-adrenergic-receptor binding in rat hippocampus. 74:37-41. 1981
- Lithium treatment decreases blood-pressure in genetically hypertensive rats. 76:411-415. 1981
- Studies on the protective effect of prostacyclin in acute myocardial ischemia. 56:95-103. 1979